Industry

DUBLIN–(BUSINESS WIRE)–The “Molecular Cytogenetics – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering. Global Molecular Cytogenetics Market to Reach $2.5 Billion by 2026 Molecular Cytogenetics involves all aspects of chromosome biology, such as structural and functional organization of the chromosome and nucleus, chromosomal variation and abnormalities, and the applications of chromosome … [Read more…]

Thanks to this operation, that is subject to the approval of the competition authorities, the Group will reach 1,300 employees in Spain and 3,500 globally, with a consolidated turnover of over 1 billion euros. Thanks to Lacer’s 5 leading brands in Spain, Italfarmaco will become the most important player in Spain’s health and personal hygiene … [Read more…]

New facilities offer innovative equipment and increased capacity to bring highly potent oncology therapies to market PHILADELPHIA–(BUSINESS WIRE)–PCI Pharma Services (PCI), a leading global contract development and manufacturing organization (CDMO), today announced a significant expansion of its world-class facility in Tredegar, Wales, UK, designed to help keep pace with the market growth of powerful, targeted … [Read more…]

HYDERABAD, India & PRINCETON, NJ–(BUSINESS WIRE)–$RDY #Bortezomib–Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the launch of Bortezomib for Injection 3.5 mg, the generic equivalent of Velcade® (bortezomib) Injection, in the U.S. market approved by the U.S. Food and … [Read more…]

13 new kits and assays allow for quantification of AAV viral titer and residual host cell DNA in cell and gene therapy Custom assay design provides dPCR users with access to tailored multiplex assays for use beyond biopharma applications Milestone achieved with over 1,000 cumulative placements of the standard-setting QIAcuity systems HILDEN, Germany & GERMANTOWN, … [Read more…]

Los Angeles Blade, City of West Hollywood and LGBTQ+, non-profit and advocacy groups partner in community event on emerging virus Expert panel to convene to discuss the emerging monkeypox crisis, the state of understanding, vaccination efforts, treatment, prevention and advocacy: As of July 20, 2022, the California Department of Health reports ~300 cases statewide Los … [Read more…]

SOMERSET, N.J.–(BUSINESS WIRE)–Legend Biotech Corporation (NASDAQ: LEGN) (“Legend Biotech”), a global biotechnology company developing, manufacturing and commercializing novel therapies to treat life-threatening diseases, today announced that it has priced an underwritten public offering of 8,140,000 American Depositary Shares (“ADSs”), each representing two ordinary shares, at a public offering price of $43.00 per ADS, for total … [Read more…]

Scores of housing Advocates to testify at Wednesday’s (July 27) Los Angeles City Council Meeting to urge City Council to preserve the city’s single room occupancy buildings (SROs) as future affordable housing LOS ANGELES–(BUSINESS WIRE)–A platoon of housing advocates affiliated with AHF and its housing advocacy division, Housing Is A Human Right (HHR), will attend … [Read more…]

MedX Health has partnered with Central Health, the second largest health authority in Newfoundland and Labrador, to introduce DermSecure® Screening Platform Services to 176 communities across the province. MISSISSAUGA, Ontario–(BUSINESS WIRE)–$MDX #SkinCancer—MedX Health Corp. (“MedX” or the “Company”) (TSXV: MDX), a global leader in teledermatology, and Central Health are pleased to announce the launch of … [Read more…]

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Enveric Biosciences, Inc. (NASDAQ: ENVB) (“Enveric” or the “Company”), a neuroscience-focused biotechnology company developing next-generation, psychedelic-inspired mental health medicines, today announced that it has closed its previously announced registered direct offering for the purchase and sale of 375,000 shares of the Company’s common stock (or pre-funded warrants in lieu thereof), priced at a … [Read more…]